Clinical Safety Guidelines for Managing Distal Shoe Complications
Soft Tissue Complications and Clinical Decision-Making in Distal Shoe Therapy: A Prospective Clinical Follow-Up Study
1 other identifier
observational
50
1 country
1
Brief Summary
Distal shoe space maintainers are the standard of care for guiding the eruption of permanent first molars following the premature loss of the primary second molars. Although this therapy represents established clinical practice, prospective evidence regarding soft tissue complications and predictors of treatment outcomes remains limited. This observational study will prospectively collect clinical outcome data during routine treatment visits. The aims of the study are to characterize patterns of complications, evaluate outcomes related to patient adherence, and identify predictors of treatment success. Ultimately, this study seeks to support the development of standardized strategies for clinical monitoring and complication management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2026
CompletedFirst Submitted
Initial submission to the registry
February 7, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
February 17, 2026
February 1, 2026
2 years
February 7, 2026
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence and severity of soft tissue complications adjacent to the distal shoe appliance
Assessment of the proportion of participants experiencing localized soft tissue complications and the graded severity of such responses. Evaluation includes the presence of gingival inflammation, ulceration, granulation tissue formation, or clinical signs of infection. These complications will be systematically documented during standardized clinical examinations at each follow-up visit. Severity will be categorized using a defined clinical scale (none, mild, moderate, severe). For participants with multiple symptoms, the overall severity will be reported based on the most severe clinical finding to arrive at one aggregated value per participant.
From appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).
Secondary Outcomes (3)
Frequency of missed follow-up appointments per participant
From appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).
Adherence to oral hygiene instructions based on clinical assessment
From appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).
Incidence of successful eruption guidance of the permanent first molar
From appliance placement until functional eruption of the permanent first molar (typically 12 to 24 months).
Study Arms (1)
Distal Shoe Therapy Cohort
This cohort includes pediatric patients, aged 3 to 9 years (ASA I or II), for whom distal shoe therapy has been clinically indicated as the standard of care (SOC). Participants undergo routine appliance fabrication and placement as part of their standard clinical care. The cohort will be prospectively monitored during SOC follow-up visits (at 1-week and 3-month intervals) to evaluate soft tissue health, gingival inflammation, and the successful eruption of the permanent first molar. Individual participation typically ranges from 12 to 24 months.
Interventions
his study involves the prospective observational monitoring of clinical outcomes during standard distal shoe therapy. Research activities consist of systematic documentation of clinical data, including radiographic assessment of the intra-alveolar blade depth measured from the mesial margin of the permanent first molar, standardized gingival health scores, and caregiver-reported compliance. No experimental modifications to the clinical device or surgical procedures are performed, ensuring the study reflects routine clinical practice.
Eligibility Criteria
The study population consists of pediatric patients recruited from the University of Florida College of Dentistry Pediatric Dental Clinic. Participants are children aged 3 to 9 years, classified as ASA I or II, who require distal shoe therapy as part of their standard clinical care following premature loss of a primary second molar. This population represents a clinical sample of children undergoing established space maintenance procedures under general anesthesia due to behavioral or clinical necessity.
You may qualify if:
- Pediatric participants aged 3 to 9 years
- American Society of Anesthesiologists (ASA) Physical Status I or II
- Clinical indication for distal shoe therapy as the standard of care
- Undergoing distal shoe space maintainer placement
- Parent or caregiver able to provide consent and comply with follow-up visits
You may not qualify if:
- Presence of systemic medical conditions that may affect bone metabolism or wound healing
- Patients unable or unwilling to comply with the planned follow-up schedule (up to 24 months)
- Patients with contraindications to distal shoe therapy based on clinical judgment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatric Dentistry, Universit of Florida, College of Dentistry
Gainesville, Florida, 32610, United States
Related Publications (1)
Brill WA. The distal shoe space maintainer chairside fabrication and clinical performance. Pediatr Dent. 2002 Nov-Dec;24(6):561-5.
PMID: 12528949BACKGROUND
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Mi Sook Lee, DMD, MSD, PhD
University of Florida
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Assistant Professor
Study Record Dates
First Submitted
February 7, 2026
First Posted
February 13, 2026
Study Start
February 1, 2026
Primary Completion (Estimated)
February 1, 2028
Study Completion (Estimated)
February 1, 2029
Last Updated
February 17, 2026
Record last verified: 2026-02